Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Gene Expression Market Trends and Forecast
3.3: Global Gene Expression Market by Product and Service
3.3.1: Consumables
3.3.1.1: Kits and Reagents
3.3.1.2: DNA Chips
3.3.2: Instruments
3.3.2.1: PCR
3.3.2.2: NGS
3.3.2.3: DNA Microarray
3.3.2.4: Others
3.3.3: Services
3.3.3.1: Gene Expression Profiling Services
3.3.1.1.1: Sequencing Services
3.3.1.1.2: Other Services
3.3.3.2: Bioinformatics Solutions
3.4: Global Gene Expression Market by Process
3.4.1: Sample Collection
3.4.2: Purification
3.4.3: cDNA Synthesis & Conversion
3.4.4: PCR Analysis
3.4.5: Data Analysis & Interpretation
3.5: Global Gene Expression Market by Capacity
3.5.1: Low- to Mid- Plex
3.5.2: High-PlexFish
3.6: Global Gene Expression Market by Technique
3.6.1: RNA Expression
3.6.1.1: Northern Blotting
3.6.1.2: DNA Microarrays
3.6.1.3: PCR Techniques
3.6.1.4: RNA-Seq
3.6.2: Promoter Analysis
3.6.2.1: In-vitro Transcription/Nuclear Run-On Assays
3.6.2.2: Gel Shift Assays
3.6.2.3: Chromatin Immunoprecipitation (ChIP)
3.6.3: Protein Expression & Posttranslational Modification Analysis
3.6.3.1: Western Blotting
3.6.3.2: 2-D Gel Electrophoresis
3.6.3.3: Immunoassays
3.6.3.4: Mass Spectrometry
3.7: Global Gene Expression Market by Application
3.7.1: Drug Discovery & Development
3.7.2: Clinical Diagnostics
3.7.3: Biotechnology & Microbiology
3.7.4: Others
3.8: Global Gene Expression Market by End User
3.8.1: Pharmaceutical and Biotech companies
3.8.2: Academic Institutes and Research Centers
3.8.3: Others
4. Market Trends and Forecast Analysis by Region
4.1: Global Gene Expression Market by Region
4.2: North American Gene Expression Market
4.2.1: Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.2.2: Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.2.3: Market by Capacity: Low- to Mid- Plex and High-Plex
4.2.4: Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.2.5: Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.2.6: Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.2.7: The United States Gene Expression Market
4.2.8: The Canadian Gene Expression Market
4.2.9: The Mexican Gene Expression Market
4.3: European Gene Expression Market
4.3.1: Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.3.2: Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.3.3: Market by Capacity: Low- to Mid- Plex and High-Plex
4.3.4: Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.3.5: Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.3.6: Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.3.7: The United Kingdom Gene Expression Market
4.3.8: The Spanish Gene Expression Market
4.3.9: The German Gene Expression Market
4.3.10: The French Gene Expression Market
4.4: APAC Gene Expression Market
4.4.1: Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.4.2: Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.4.3: Market by Capacity: Low- to Mid- Plex and High-Plex
4.4.4: Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.4.5: Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.4.6: Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.4.7: The Chinese Gene Expression Market
4.4.8: The Indian Gene Expression Market
4.4.9: The Japanese Gene Expression Market
4.5: ROW Gene Expression Market
4.5.1: Market by Product and Service: Consumables (Kits and Reagents and DNA Chips), Instruments (PCR, NGS, DNA Microarray, and Others), and Services (Gene Expression Profiling Services (Sequencing Services and Other Services) and Bioinformatics Solutions)
4.5.2: Market by Process: Sample Collection, Purification, Cdna Synthesis & Conversion, PCR Analysis, and Data Analysis & Interpretation
4.5.3: Market by Capacity: Low- to Mid- Plex and High-Plex
4.5.4: Market by Technique: RNA Expression (Northern Blotting, DNA Microarrays, PCR Techniques, and RNA-Seq), Promoter Analysis (In-Vitro Transcription/Nuclear Run-On Assays, Gel Shift Assays, and Chromatin Immunoprecipitation (Chip)), and Protein Expression & Posttranslational Modification Analysis (Western Blotting, 2-D Gel Electrophoresis, Immunoassays, and Mass Spectrometry)
4.5.5: Market by Application: Drug Discovery & Development, Clinical Diagnostics, Biotechnology & Microbiology, and Others
4.5.6: Market by End User: Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others
4.5.7: Brazilian Gene Expression Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Gene Expression Market by Product and Service
7.1.2: Growth Opportunities for the Global Gene Expression Market by Process
7.1.3: Growth Opportunities for the Global Gene Expression Market by Capacity
7.1.4: Growth Opportunities for the Global Gene Expression Market by Technique
7.1.5: Growth Opportunities for the Global Gene Expression Market by Application
7.1.6: Growth Opportunities for the Global Gene Expression Market by End User
7.1.7: Growth Opportunities for the Global Gene Expression Market by Region
7.2: Emerging Trends in the Global Gene Expression Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Gene Expression Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Expression Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Illumina
8.2: Thermo Fisher Scientific
8.3: Bio-Rad Laboratories
8.4: F. Hoffmann-La Roche
8.5: GE Healthcare
8.6: Pacific Biosciences of California
8.7: Agilent Technologies
8.8: QIAGEN
8.9: Oxford Gene Technologies
8.10: Eurofins Scientific